Gateway 2012: Cambridge Major Laboratories - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe

Gateway 2012: Cambridge Major Laboratories


CAMBRIDGE MAJOR LABORATORIES – CRYSTALLIZATION AND SOLID STATE CHEMISTRY SERVICES

Cambridge Major Laboratories (CML) has established a new Center of Excellence for Crystallization and Solid State Chemistry in our Active Pharmaceutical Ingredient (API) development facilities in the Netherlands. Significant investments have been made in equipment and personnel as part of CML’s expansion into solid state services.

CML'S Solid State Chemistry Services

  • Crystallization Study – crystallize to obtain stable solids, for purification or isolation
  • Material Characterization – polymorph identification
  • Solubility Determination – in production solvents and buffer solutions
  • Salt Selection – suitable form selection
  • Polymorph Study – behavior in production solvents
  • Crystallization Process Development – combine optimal synthesis conditions with optimal crystallization conditions
  • Crystal Habit Optimization – control of particle size and shape

CML Overview

Analytical Services

API Manufacturing

Process Chemistry

Quality Assurance

Solid State Chemistry

ADVERTISEMENT

blog comments powered by Disqus
LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
Which of the following business challenge poses the greatest threat to your company?
Building a sustainable pipeline of products
Attracting a skilled workforce
Obtaining/maintaining adequate financing
Regulatory compliance
Building a sustainable pipeline of products
25%
Attracting a skilled workforce
31%
Obtaining/maintaining adequate financing
13%
Regulatory compliance
31%
View Results
Eric Langer Outsourcing Outlook Eric LangerBiopharma Outsourcing Activities Update
Cynthia Challener, PhD Ingredients Insider Cynthia Challener, PhDAppropriate Process Design Critical for Commercial Manufacture of Highly Potent APIs
Jill Wechsler Regulatory Watch Jill Wechsler FDA and Manufacturers Seek a More Secure Drug Supply Chain
Sean Milmo European Regulatory WatcchSean MilmoQuality by Design?Bridging the Gap between Concept and Implementation
Medicare Payment Data Raises Questions About Drug Costs
FDA Wants You!
A New Strategy to Tackle Antibiotic Resistance
Drug-Diagnostic Development Stymied by Payer Concerns
Obama Administration Halts Attack on Medicare Drug Plans

Click here